Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MMP1 | P03956 | 1/20 | 0.34 |
| ▸ | MMP2 | P08253 | 1/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.34 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA9 | Q16790 | 3/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL381408 | 0.80 | MMP1 (0.37) | ALDH1A1MMP1MMP2MMP3MMP8 | |
| SCHEMBL1548681 | 0.78 | ALDH1A1 (0.36) | ALDH1A1MMP1MMP2MMP3MMP8 | |
| SCHEMBL15121410 | 0.78 | MMP1 (0.35) | ALDH1A1MMP1MMP2MMP3MMP8 | |
| SCHEMBL15121451 | 0.78 | MMP1 (0.35) | ALDH1A1MMP1MMP2MMP3MMP8 | |
| SCHEMBL976818 | 0.78 | MMP1 (0.35) | ALDH1A1MMP1MMP2MMP3MMP8 | |
| SCHEMBL19313015 | 0.76 | FDPS (0.37) | — | |
| SCHEMBL11791595 | 0.76 | MMP1 (0.34) | ALDH1A1MMP1MMP2MMP3MMP8 | |
| SCHEMBL10601926 | 0.76 | GPR84 (0.40) | HTTSPHK1 | |
| SCHEMBL30229787 | 0.76 | DNM1 (0.39) | MMP1MMP2MMP3MMP8CA12 | |
| SCHEMBL1966027 | 0.74 | GPR84 (0.43) | HTTSPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10799610-B2 | Cement products and methods of making and using the same | PIONEER SURGICAL TECHNOLOGY, INC. (US) | 2020-10-13 | — | — | US | disclosed |
| US-10413632-B2 | Cement products and methods of making and using the same | PIONEER SURGICAL TECHNOLOGY, INC. (US) | 2019-09-17 | — | — | US | disclosed |
| US-20180264165-A1 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | MIDCAP FINANCIAL TRUST | 2018-09-20 | — | — | US | disclosed |
| US-9993576-B2 | Cement products and methods of making and using the same | PIONEER SURGICAL TECHNOLOGY, INC. (US) | 2018-06-12 | — | — | US | disclosed |
| EP-2192886-B1 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | PIONEER SURGICAL TECH INC (US) | 2017-12-20 | — | — | EP | disclosed |
| US-20170333594-A1 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | MIDCAP FINANCIAL TRUST | 2017-11-23 | — | — | US | disclosed |
| US-9757493-B2 | Cement products and methods of making and using the same | PIONEER SURGICAL TECHNOLOGY, INC. (US) | 2017-09-12 | — | — | US | disclosed |
| US-20160250376-A1 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | TUTOGEN MEDICAL, INC. | 2016-09-01 | — | — | US | disclosed |
| US-9358319-B2 | Cement products and methods of making and using the same | PIONEER SURGICAL TECHNOLOGY, INC. (US) | 2016-06-07 | — | — | US | disclosed |
| EP-2877540-B1 | CURABLE ANTIFOULING COMPOSITION, METHOD OF USE, AND ARTICLES | 3M INNOVATIVE PROPERTIES CO (US) | 2016-06-01 | — | — | EP | disclosed |
| US-20090270527-A1 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | ANGSTROM MEDICA (US) | 2009-10-29 | — | — | US | disclosed |
| WO-2009029734-A2 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | PIONEER SURGICAL TECHNOLOGY, INC. (US) | 2009-03-05 | — | — | WO | disclosed |
| US-7060352-B2 | Method of detackifying an edge face of a roll of tape using a radiation curable composition | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2006-06-13 | — | — | US | disclosed |
| EP-1373423-B1 | METHOD OF DETACKIFYING AN EDGE FACE OF A ROLL OF TAPE USING A RADIATION CURABLE COMPOSITION | 3M INNOVATIVE PROPERTIES CO (US) | 2006-03-29 | — | — | EP | disclosed |
| CN-1247721-C | Method of detackifying an edge face of a roll of tape using a radiation curable composition | 3M INNOVATIVE PROPERTIES CO (US) | 2006-03-29 | — | — | CN | disclosed |
| CN-1492915-A | Method for detackifying an edge face of a roll of tape using a radiation curable composition | 3M | 2004-04-28 | — | — | CN | disclosed |
| EP-1373423-A1 | METHOD OF DETACKIFYING AN EDGE FACE OF A ROLL OF TAPE USING A RADIATION CURABLE COMPOSITION | 3M Innovative Properties Company (US) | 2004-01-02 | — | — | EP | disclosed |
| US-20020168514-A1 | Method of detackifying an edge face of a roll of tape using a radiation curable composition | 3M INNOVATIVE PROPERTIES COMPANY | 2002-11-14 | — | — | US | disclosed |
| WO-2002074875-A1 | METHOD OF DETACKIFYING AN EDGE FACE OF A ROLL OF TAPE USING A RADIATION CURABLE COMPOSITION | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2002-09-26 | — | — | WO | disclosed |
| US-4332733-A | CATALYTIC ISOMERIZATION OF DIELS-ALDER MALEIC ANHYDRIDE PRODUCTS | MITSUBISHI PETROCHEMICAL CO., LTD. (JP) | 1982-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180264165-A1 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | BHMT2, SHMT1, BHMT | HTT 376/4885ALDH1A1 844/4885TDP1 4090/4885 |
| US-20160250376-A1 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | BHMT2, SHMT1, BHMT | HTT 376/4885ALDH1A1 844/4885TDP1 4090/4885 |
| US-20170333594-A1 | CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME | BHMT2, SHMT1, BHMT | HTT 376/4885ALDH1A1 844/4885TDP1 4090/4885 |
| US-10799610-B2 | Cement products and methods of making and using the same | BHMT2, SHMT1, BHMT | HTT 376/4885ALDH1A1 844/4885TDP1 4090/4885 |
| US-10413632-B2 | Cement products and methods of making and using the same | BHMT2, SHMT1, BHMT | HTT 376/4885ALDH1A1 844/4885TDP1 4090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.